Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

98.68
+1.741.79%
Post-market: 98.62-0.0592-0.06%19:30 EDT
Volume:128.25K
Turnover:12.62M
Market Cap:406.56M
PE:55.03
High:98.68
Open:97.34
Low:97.30
Close:96.94
52wk High:98.82
52wk Low:67.69
Shares:4.12M
Float Shares:4.12M
Volume Ratio:6.45
T/O Rate:3.11%
Dividend:1.55
Dividend Rate:1.57%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.64
PE(LYR):5.29

Loading ...

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Sep 01

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS
·
Sep 01

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Sep 01

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Sep 01

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Biogen, Eisai announce positive recommendation for Leqembi in Canada

TIPRANKS
·
Sep 01

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS
·
Sep 01

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live
·
Aug 31

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Reuters
·
Aug 31

Political and General News Events from August 31

Reuters
·
Aug 31

Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation

Reuters
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Alnylam announces new data at ESC Congress on AMVUTTRA

TIPRANKS
·
Aug 31

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29